Fibrocyte accumulation in the airway walls of COPD patients
The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exac...
Saved in:
Published in | The European respiratory journal Vol. 54; no. 3; p. 1802173 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
European Respiratory Society
01.09.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0903-1936 1399-3003 1399-3003 |
DOI | 10.1183/13993003.02173-2018 |
Cover
Loading…
Abstract | The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study).
A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.
We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.
Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors. |
---|---|
AbstractList | The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density
in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival
("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45
FSP1
cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors. The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study). A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients. We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival. Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors. The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro (“Fibrochir” study). A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45 + FSP1 + cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients. We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival. Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors. The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro ("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45+ FSP1+ cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors.The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that circulating fibrocytes, a rare population of fibroblast-like cells produced by the bone marrow stroma, are increased in COPD patients during an exacerbation. We aimed to quantify fibrocyte density in situ in bronchial specimens from both control subjects and COPD patients, to define associations with relevant clinical, functional and computed tomography (CT) parameters, and to investigate the effect of the epithelial microenvironment on fibrocyte survival in vitro ("Fibrochir" study).A total of 17 COPD patients and 25 control subjects, all requiring thoracic surgery, were recruited. Using co-immunostaining and image analysis, we identified CD45+ FSP1+ cells as tissue fibrocytes, and quantified their density in distal and proximal bronchial specimens. Fibrocytes, cultured from the blood samples of six COPD patients, were exposed to primary bronchial epithelial cell secretions from control subjects or COPD patients.We demonstrate that fibrocytes are increased in both distal and proximal tissue specimens of COPD patients. The density of fibrocytes is negatively correlated with lung function parameters and positively correlated with bronchial wall thickness as assessed by CT scan. A high density of distal bronchial fibrocytes predicts the presence of COPD with a sensitivity of 83% and a specificity of 70%. Exposure of fibrocytes to COPD epithelial cell supernatant favours cell survival.Our results thus demonstrate an increased density of fibrocytes within the bronchi of COPD patients, which may be promoted by epithelial-derived survival-mediating factors. |
Author | Trian, Thomas Girodet, Pierre-Olivier Montaudon, Michel Thumerel, Matthieu Marthan, Roger Berger, Patrick Dupin, Isabelle Begueret, Hugues Maurat, Elise Eyraud, Edmée Coste, Florence |
Author_xml | – sequence: 1 givenname: Isabelle orcidid: 0000-0002-4992-9625 surname: Dupin fullname: Dupin, Isabelle – sequence: 2 givenname: Matthieu orcidid: 0000-0003-4673-8433 surname: Thumerel fullname: Thumerel, Matthieu – sequence: 3 givenname: Elise surname: Maurat fullname: Maurat, Elise – sequence: 4 givenname: Florence orcidid: 0000-0001-5858-8327 surname: Coste fullname: Coste, Florence – sequence: 5 givenname: Edmée surname: Eyraud fullname: Eyraud, Edmée – sequence: 6 givenname: Hugues surname: Begueret fullname: Begueret, Hugues – sequence: 7 givenname: Thomas surname: Trian fullname: Trian, Thomas – sequence: 8 givenname: Michel surname: Montaudon fullname: Montaudon, Michel – sequence: 9 givenname: Roger surname: Marthan fullname: Marthan, Roger – sequence: 10 givenname: Pierre-Olivier surname: Girodet fullname: Girodet, Pierre-Olivier – sequence: 11 givenname: Patrick orcidid: 0000-0003-4702-0343 surname: Berger fullname: Berger, Patrick |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31196946$$D View this record in MEDLINE/PubMed https://hal.science/hal-03457269$$DView record in HAL |
BookMark | eNp9kUtPwzAQhC1URB_wC5BQjnBIsbOJHYtTVShFqlQOcLY2jqMapUmJE6r-e5K-Dhw4rTT6Zlc7MyS9oiwMIbeMjhmL4ZGBlEApjGnABPgBZfEFGXSq38k9MqCSgs8k8D4ZOvdFKeMhsCvSB8YklyEfkKeZTapS72rjodbNusmxtmXh2cKrV61mqy3uvC3mufPKzJsu35-9TYuYonbX5DLD3Jmb4xyRz9nLx3TuL5avb9PJwtcAsvZRtkeFjjA2QmuZ6RSDKAHJgMdxRCMuRSQwRUE5xSTFNKQ6FSajaMIk4wZG5OGwd4W52lR2jdVOlWjVfLJQnUYhjETA5Q9r2fsDu6nK78a4Wq2t0ybPsTBl41QQxO3jIHjUondHtEnWJj1vPoXTAnAAdFU6V5nsjDCqugrUqQK1r0B1FbQu-celbb0Pta7Q5v96fwH7O4gO |
CitedBy_id | crossref_primary_10_1007_s00408_024_00720_3 crossref_primary_10_2139_ssrn_3903927 crossref_primary_10_1111_resp_14115 crossref_primary_10_1016_j_jtbi_2023_111448 crossref_primary_10_1164_rccm_202206_1041ST crossref_primary_10_1080_17460751_2024_2378627 crossref_primary_10_1016_j_intimp_2025_114241 crossref_primary_10_1016_j_rmr_2022_11_015 crossref_primary_10_2147_COPD_S261522 crossref_primary_10_1093_toxres_tfad016 crossref_primary_10_2147_COPD_S436803 crossref_primary_10_3390_bioengineering8110163 crossref_primary_10_1016_j_rmr_2022_01_010 crossref_primary_10_1002_jcsm_13103 crossref_primary_10_3389_fphar_2022_939780 crossref_primary_10_1111_ped_15058 crossref_primary_10_1080_17476348_2024_2380070 crossref_primary_10_1093_ibd_izab157 crossref_primary_10_1183_13993003_01221_2021 crossref_primary_10_7554_eLife_85875_3 crossref_primary_10_1183_16000617_0289_2020 crossref_primary_10_7554_eLife_85875 crossref_primary_10_1186_s12931_023_02509_z crossref_primary_10_3389_fimmu_2022_852713 crossref_primary_10_1016_j_rmr_2022_03_013 |
Cites_doi | 10.1056/NEJMoa032158 10.1016/S0873-2159(15)30121-5 10.1164/rccm.201410-1874OC 10.1164/rccm.200311-1535OC 10.1165/rcmb.2017-0301PS 10.4049/jimmunol.171.1.380 10.1007/BF03403533 10.1038/ncomms9792 10.1056/NEJMoa1516385 10.1164/rccm.201408-1423OC 10.1097/00001648-199001000-00010 10.1164/rccm.200601-037OC 10.1056/NEJMoa1713901 10.1165/rcmb.2013-0455OC 10.1136/thx.2005.040527 10.1186/1465-9921-7-50 10.1136/thoraxjnl-2015-207696 10.1172/JCI200420997 10.1056/NEJMoa063070 10.1152/physrev.00025.2015 10.1183/09031936.06.00124605 10.1038/nri2990 10.1016/S0140-6736(16)30069-1 10.1186/s12931-018-0798-8 10.1083/jcb.130.2.393 10.1016/j.jaci.2008.10.048 10.1016/j.jaci.2015.08.043 10.1007/978-1-4939-2963-4_3 10.1056/NEJM197410102911503 10.1148/radiol.2422060029 10.1371/journal.pone.0007475 10.1164/rccm.201503-0487OC 10.1111/j.1582-4934.2011.01344.x 10.1111/j.1523-1755.2005.00358.x 10.1056/NEJM196806202782501 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7 10.1111/resp.12780 10.1016/j.ajpath.2011.08.027 10.1164/rccm.201409-1582OC 10.1016/j.chest.2016.10.031 10.1111/all.13061 10.1073/pnas.1117988108 10.1378/chest.12-1766 |
ContentType | Journal Article |
Copyright | Copyright ©ERS 2019. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Copyright ©ERS 2019. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION NPM 7X8 1XC |
DOI | 10.1183/13993003.02173-2018 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3003 |
ExternalDocumentID | oai_HAL_hal_03457269v1 31196946 10_1183_13993003_02173_2018 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 18M 1OC 2WC 31~ 3O- 53G 5GY 5RE 5VS 8-1 AADJU AAFWJ AAYXX AAZMJ ABCQX ABJNI ABOCM ABSQV ACEMG ACGFO ACPRK ACXQS ADBBV ADDZX ADMOG ADYFA AENEX AFFNX AFHIN AFZJQ AIZTS AJAOE ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CAG CITATION COF CS3 DIK E3Z EBS EJD F5P F9R GX1 H13 INIJC J5H KQ8 L7B LH4 LW6 OK1 P2P PQQKQ R0Z RHI TER TR2 W8F WOQ X7M ZE2 ZGI ZXP ~02 NPM RHF 7X8 1XC |
ID | FETCH-LOGICAL-c339t-a94317c5a8e7cc9fcda25b391368850569757ada7060abdad40cd7ef0ae4bf6e3 |
ISSN | 0903-1936 1399-3003 |
IngestDate | Sat Aug 23 06:30:58 EDT 2025 Fri Jul 11 04:40:07 EDT 2025 Wed Feb 19 02:30:21 EST 2025 Tue Jul 01 05:40:07 EDT 2025 Thu Apr 24 23:03:05 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright ©ERS 2019. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c339t-a94317c5a8e7cc9fcda25b391368850569757ada7060abdad40cd7ef0ae4bf6e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0003-4673-8433 0000-0002-4992-9625 0000-0003-4702-0343 0000-0001-5858-8327 |
PMID | 31196946 |
PQID | 2286943765 |
PQPubID | 23479 |
ParticipantIDs | hal_primary_oai_HAL_hal_03457269v1 proquest_miscellaneous_2286943765 pubmed_primary_31196946 crossref_primary_10_1183_13993003_02173_2018 crossref_citationtrail_10_1183_13993003_02173_2018 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-09-01 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | The European respiratory journal |
PublicationTitleAlternate | Eur Respir J |
PublicationYear | 2019 |
Publisher | European Respiratory Society |
Publisher_xml | – name: European Respiratory Society |
References | 2024102101003485000_54.3.1802173.34 2024102101003485000_54.3.1802173.33 2024102101003485000_54.3.1802173.14 2024102101003485000_54.3.1802173.36 Jenkins (2024102101003485000_54.3.1802173.42) 2017; 151 2024102101003485000_54.3.1802173.35 2024102101003485000_54.3.1802173.16 2024102101003485000_54.3.1802173.37 2024102101003485000_54.3.1802173.18 2024102101003485000_54.3.1802173.17 2024102101003485000_54.3.1802173.39 Xue (2024102101003485000_54.3.1802173.45) 2003; 63 2024102101003485000_54.3.1802173.30 2024102101003485000_54.3.1802173.10 2024102101003485000_54.3.1802173.32 2024102101003485000_54.3.1802173.19 Dupin (2024102101003485000_54.3.1802173.38) 2018; 58 Mitsuhashi (2024102101003485000_54.3.1802173.15) 2015; 6 2024102101003485000_54.3.1802173.1 2024102101003485000_54.3.1802173.23 Vestbo (2024102101003485000_54.3.1802173.7) 2016; 387 2024102101003485000_54.3.1802173.22 2024102101003485000_54.3.1802173.44 2024102101003485000_54.3.1802173.25 2024102101003485000_54.3.1802173.2 2024102101003485000_54.3.1802173.24 2024102101003485000_54.3.1802173.5 2024102101003485000_54.3.1802173.27 2024102101003485000_54.3.1802173.4 2024102101003485000_54.3.1802173.26 2024102101003485000_54.3.1802173.29 2024102101003485000_54.3.1802173.6 2024102101003485000_54.3.1802173.28 Dupin (2024102101003485000_54.3.1802173.12) 2016; 137 Bucala (2024102101003485000_54.3.1802173.11) 1994; 1 Hu (2024102101003485000_54.3.1802173.31) 2015; 1343 2024102101003485000_54.3.1802173.40 Heukels (2024102101003485000_54.3.1802173.41) 2018; 19 2024102101003485000_54.3.1802173.21 2024102101003485000_54.3.1802173.43 2024102101003485000_54.3.1802173.20 Wright (2024102101003485000_54.3.1802173.13) 2017; 72 2024102101003485000_54.3.1802173.9 2024102101003485000_54.3.1802173.8 Ko (2024102101003485000_54.3.1802173.3) 2016; 21 |
References_xml | – ident: 2024102101003485000_54.3.1802173.1 doi: 10.1056/NEJMoa032158 – ident: 2024102101003485000_54.3.1802173.6 doi: 10.1016/S0873-2159(15)30121-5 – ident: 2024102101003485000_54.3.1802173.21 doi: 10.1164/rccm.201410-1874OC – ident: 2024102101003485000_54.3.1802173.27 doi: 10.1164/rccm.200311-1535OC – volume: 58 start-page: 288 year: 2018 ident: 2024102101003485000_54.3.1802173.38 article-title: Fibrocytes in asthma and chronic obstructive pulmonary disease: variations on the same theme publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2017-0301PS – ident: 2024102101003485000_54.3.1802173.14 doi: 10.4049/jimmunol.171.1.380 – volume: 1 start-page: 71 year: 1994 ident: 2024102101003485000_54.3.1802173.11 article-title: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair publication-title: Mol Med doi: 10.1007/BF03403533 – volume: 6 start-page: 8792 year: 2015 ident: 2024102101003485000_54.3.1802173.15 article-title: Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab publication-title: Nat Commun doi: 10.1038/ncomms9792 – ident: 2024102101003485000_54.3.1802173.8 doi: 10.1056/NEJMoa1516385 – ident: 2024102101003485000_54.3.1802173.20 doi: 10.1164/rccm.201408-1423OC – ident: 2024102101003485000_54.3.1802173.24 doi: 10.1097/00001648-199001000-00010 – ident: 2024102101003485000_54.3.1802173.35 doi: 10.1164/rccm.200601-037OC – ident: 2024102101003485000_54.3.1802173.9 doi: 10.1056/NEJMoa1713901 – ident: 2024102101003485000_54.3.1802173.18 doi: 10.1165/rcmb.2013-0455OC – ident: 2024102101003485000_54.3.1802173.4 doi: 10.1136/thx.2005.040527 – ident: 2024102101003485000_54.3.1802173.39 doi: 10.1186/1465-9921-7-50 – ident: 2024102101003485000_54.3.1802173.19 doi: 10.1136/thoraxjnl-2015-207696 – ident: 2024102101003485000_54.3.1802173.30 doi: 10.1172/JCI200420997 – ident: 2024102101003485000_54.3.1802173.5 doi: 10.1056/NEJMoa063070 – ident: 2024102101003485000_54.3.1802173.37 doi: 10.1152/physrev.00025.2015 – ident: 2024102101003485000_54.3.1802173.25 doi: 10.1183/09031936.06.00124605 – ident: 2024102101003485000_54.3.1802173.26 doi: 10.1038/nri2990 – volume: 387 start-page: 1817 year: 2016 ident: 2024102101003485000_54.3.1802173.7 article-title: Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(16)30069-1 – volume: 19 start-page: 90 year: 2018 ident: 2024102101003485000_54.3.1802173.41 article-title: Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis publication-title: Respir Res doi: 10.1186/s12931-018-0798-8 – ident: 2024102101003485000_54.3.1802173.28 doi: 10.1083/jcb.130.2.393 – ident: 2024102101003485000_54.3.1802173.40 doi: 10.1016/j.jaci.2008.10.048 – volume: 137 start-page: 1036 year: 2016 ident: 2024102101003485000_54.3.1802173.12 article-title: Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2015.08.043 – volume: 1343 start-page: 19 year: 2015 ident: 2024102101003485000_54.3.1802173.31 article-title: Flow cytometric identification of fibrocytes in the human circulation publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-2963-4_3 – ident: 2024102101003485000_54.3.1802173.10 doi: 10.1056/NEJM197410102911503 – ident: 2024102101003485000_54.3.1802173.22 doi: 10.1148/radiol.2422060029 – ident: 2024102101003485000_54.3.1802173.32 doi: 10.1371/journal.pone.0007475 – ident: 2024102101003485000_54.3.1802173.43 doi: 10.1164/rccm.201503-0487OC – ident: 2024102101003485000_54.3.1802173.33 doi: 10.1111/j.1582-4934.2011.01344.x – ident: 2024102101003485000_54.3.1802173.2 – ident: 2024102101003485000_54.3.1802173.29 doi: 10.1111/j.1523-1755.2005.00358.x – ident: 2024102101003485000_54.3.1802173.34 doi: 10.1056/NEJM196806202782501 – ident: 2024102101003485000_54.3.1802173.44 doi: 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7 – volume: 21 start-page: 1152 year: 2016 ident: 2024102101003485000_54.3.1802173.3 article-title: Acute exacerbation of COPD publication-title: Respirology doi: 10.1111/resp.12780 – ident: 2024102101003485000_54.3.1802173.16 doi: 10.1016/j.ajpath.2011.08.027 – ident: 2024102101003485000_54.3.1802173.23 doi: 10.1164/rccm.201409-1582OC – volume: 151 start-page: 686 year: 2017 ident: 2024102101003485000_54.3.1802173.42 article-title: Improving the management of COPD in women publication-title: Chest doi: 10.1016/j.chest.2016.10.031 – volume: 72 start-page: 645 year: 2017 ident: 2024102101003485000_54.3.1802173.13 article-title: Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease publication-title: Allergy doi: 10.1111/all.13061 – ident: 2024102101003485000_54.3.1802173.17 doi: 10.1073/pnas.1117988108 – ident: 2024102101003485000_54.3.1802173.36 doi: 10.1378/chest.12-1766 – volume: 63 start-page: 3386 year: 2003 ident: 2024102101003485000_54.3.1802173.45 article-title: The gatekeeper effect of epithelial–mesenchymal transition regulates the frequency of breast cancer metastasis publication-title: Cancer Res |
SSID | ssj0016431 |
Score | 2.4217703 |
Snippet | The remodelling mechanism and cellular players causing persistent airflow limitation in COPD remain largely elusive. We have recently demonstrated that... |
SourceID | hal proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1802173 |
SubjectTerms | Life Sciences |
Title | Fibrocyte accumulation in the airway walls of COPD patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31196946 https://www.proquest.com/docview/2286943765 https://hal.science/hal-03457269 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZNCqWX0ne3L9zSW-vUtiw_6ClssmzaTdLDLuxNSLJMFrZ22LUb0l_fGVl-BLYl7cUYYcn2zMcwo9F8Q8iHiGW5CETgpgmmGSXNXPDyfTcIGUs8mfvSZExPz6LpIvy6ZMu-raKpLqnkgfq1s67kf7QKY6BXrJL9B812i8IA3IN-4QoahuutdDyBWLdU1xVSYqj6h-3E1R5dFKvNlbj-eCXWDUPy-Pz7Ucujuh06pQiVbld-M8i9Dz_COLuXDePAyVZgvqLDxPwCqzibfL9pIL7Sdb_VXcNq9gRZnwkaY3GJ8ZzXpSk4HG4_-P35qtZigofjUs9rrJTeMWbNbMMVbeFEd1vvBFkkcDZOPsBwiYLCrYG-wZV9ds4ni9mMz4-X8z1yN4AgAftXHJ1863JI4Gs14bb9GMs5BS_5vOMVN_ySvQs8FfunkMO4HvOH5IGNGZzDBgCPyB1dPCb3Tu2piCfkS4cDZ4gDZ1U4gAOnwYFjcOCUuYM4cFocPCWLyfF8PHVtUwxXUZpWrkjR5VNMJDpWKs1VJgImaerTKEnQnU1jFotMICuSkJnIQk9lsc49oUOZR5o-I_tFWegXxEHmo1RSnbFQhLEUiYxEwhLly8yPZRCNSNCKhCvLGI-NS9bcRI4J5a0cuZEjRzmOyKdu0mVDmPL3x9-DrLsnkex8ejjjOObRkMVBlP70R-RdqwoO1g9TWqLQZb3l8AsRCCSO2Ig8b3TUrUV9pH4Ko5e3mP2K3O_B_ZrsV5tavwFvs5JvDah-AygveVs |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibrocyte+accumulation+in+the+airway+walls+of+COPD+patients&rft.jtitle=The+European+respiratory+journal&rft.au=Dupin%2C+Isabelle&rft.au=Thumerel%2C+Matthieu&rft.au=Maurat%2C+Elise&rft.au=Coste%2C+Florence&rft.date=2019-09-01&rft.issn=1399-3003&rft.eissn=1399-3003&rft.volume=54&rft.issue=3&rft_id=info:doi/10.1183%2F13993003.02173-2018&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon |